SCHEMBL821820

SCHEMBL821820

CC=CC(=O)NCC=CO

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 9/20 0.36
CNR1 P21554 7/20 0.36
PPARG P37231 2/20 0.36
PPARD Q03181 2/20 0.36
PPARA Q07869 2/20 0.36
TRPA1 O75762 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
APEX1 P27695 1/20 0.33
TGM2 P21980 1/20 0.32
GFPT1 Q06210 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28820746 0.86 PPARG (0.42) CNR2CNR1PPARGPPARDPPARA
SCHEMBL12785469 0.81 CNR2 (0.50) CNR2CNR1PPARGPPARDPPARA
SCHEMBL18828200 0.79 PPARG (0.49) CNR2CNR1PPARGPPARDPPARA
SCHEMBL282534 0.77
SCHEMBL10499492 0.76
SCHEMBL307121 0.76
SCHEMBL14642043 0.74 SMN1; SMN2 (0.46) CNR2CNR1PPARGPPARDPPARA
SCHEMBL22187119 0.74 SMN1; SMN2 (0.46) CNR2CNR1PPARGPPARDPPARA
SCHEMBL327709 0.73
SCHEMBL11797058 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11999865-B2 UV curable composition for use in 3D printing BASF SE (DE) 2024-06-04 US disclosed
EP-3856856-B1 UV CURABLE COMPOSITION FOR USE IN 3D PRINTING BASF SE (DE) 2024-05-29 EP disclosed
US-11897995-B2 Allophanate based dispersing agent BASF SE (DE) 2024-02-13 US disclosed
EP-4041830-B1 THERMALLY CURABLE TWO-COMPONENT COATING COMPOUNDS BASF SE (DE) 2023-12-06 EP disclosed
EP-3911687-B1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2023-11-01 EP disclosed
EP-3870618-B1 AQUEOUS BINDER FORMULATION BASED ON FUNCTIONALIZED POLYURETHANES BASF SE (DE) 2023-07-12 EP disclosed
US-20230002631-A1 WATER-WASHABLE COMPOSITIONS FOR USE IN 3D PRINTING BASF SE (DE) 2023-01-05 US disclosed
CN-114502668-A Thermally curable two-component coating composition 巴斯夫欧洲公司 2022-05-13 CN disclosed
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2022-03-03 US disclosed
US-20210395558-A1 UV CURABLE COMPOSITION FOR USE IN 3D PRINTING BASF SE (DE) 2021-12-23 US disclosed
US-7169841-B2 Curable aqueous polyurethane dispersions BASF AKTIENGESELLSCHAFT (DE) 2007-01-30 US disclosed
US-20050260405-A1 Radiation-curable paint systems having a lower layer with low-temperature elasticity BASF AKTIENGESELLSCHAFT (DE) 2005-11-24 US disclosed
US-20050244652-A1 Radiation curable polyurethanes with capped amino groups BASF AKTIENGESELLSCHAFT (DE) 2005-11-03 US disclosed
US-20050222294-A1 Acyl- and bisacylphosphine derivatives IGM GROUP B.V. (NL) 2005-10-06 US disclosed
US-6916854-B2 Heat and/or light curable films or coatings comprising polyurethanes or polyureaurethane copolymers having storage stability, used as automobile paints BASF AKTIENGESELLSCHAFT (DE) 2005-07-12 US disclosed
US-20050025903-A1 Radiation-hardened coatings with improved adhesive strength BASF AKTIENGESELLSCHAFT (DE) 2005-02-03 US disclosed
US-6747088-B1 COATING HEAT-STABLE SUBSTRATES SUCH AS METAL SUBSTRATES AND MAY BE USED WITH ADVANTAGE FOR AUTOMOTIVE CLEARCOATS. BASF AKTIENGESELLSCHAFT (DE) 2004-06-08 US disclosed
US-20040097642-A1 Unsaturated compounds containing carbamate terminal groups or urea terminal groups BASF AKTIENGESELLSCHAFT (DE) 2004-05-20 US disclosed
US-6617413-B1 With or without blocking, allophanate groups and free-radically polymerizable C=C double bonds in activated form by a carbonyl group attached directly or an oxygen atom in an ether function BASF AKTIENGESELLSCHAFT (DE) 2003-09-09 US disclosed
US-20030153673-A1 Curable aqueous polyurethane dispersions BASF AKTIENGESELLSCHAFT (DE) 2003-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING LIMK1, LIMA1, LIMK2 CNR2 4836/4885CNR1 4688/4885PPARG 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.